Inclisiran is a medicine used to reduce the risk of cardiovascular events, such as heart attack, stroke, or death, in adults with atherosclerotic cardiovascular disease (ASCVD). It is a small interfering ribonucleic acid (siRNA) drug that inhibits the production of PCSK9, a protein that increases the amount of cholesterol in the bloodstream. Inclisiran is given as an injection into the fatty tissue under the skin, typically in the abdomen, thigh, or upper arm. It is given once every 6 months, and treatment should continue as long as it is working and the benefits are greater than the risks.
Inclisiran, sold under the brand name Leqvio, is a medication specifically designed to reduce low-density lipoprotein (LDL) cholesterol, often referred to as "bad cholesterol", in the bloodstream.
Here's a comprehensive overview of Inclisiran:
Function:
- Inclisiran belongs to a new class of drugs called small interfering RNA (siRNA).
- It targets a specific protein called proprotein convertase subtilisin/kexin type 9 (PCSK9).
- PCSK9 plays a role in regulating LDL cholesterol levels. By silencing the gene responsible for PCSK9 production, Inclisiran helps the liver remove more LDL cholesterol from the blood.
Applications:
- Inclisiran is primarily used for adults with:
- Familial heterozygous hypercholesterolemia (HeFH): An inherited condition where the body struggles to eliminate LDL cholesterol effectively.
- Atherosclerotic cardiovascular disease (ASCVD): A condition characterized by plaque buildup in the arteries, which can lead to heart attack, stroke, and other cardiovascular complications.
- It's usually prescribed in combination with other cholesterol-lowering medications like statins, especially when other approaches haven't adequately managed LDL levels.
Key Points:
- Dosage: Administered via subcutaneous injection with a specific dosing schedule (usually starting with initial doses followed by subsequent injections at set intervals).
- Effectiveness: Studies have shown Inclisiran to be highly effective in significantly reducing LDL cholesterol levels, with reductions of around 50% compared to placebo.
- Advantages: Offers a long-lasting effect, requiring fewer doses compared to some other cholesterol medications.
Important Considerations:
- Inclisiran is a prescription medication and should only be used under the supervision of a qualified healthcare professional.
- It can cause side effects, including injection site reactions, inflammation, and potential liver issues.
- Pregnant or breastfeeding women should not take Inclisiran.
- It's crucial to disclose any medical conditions and current medications to your doctor before starting Inclisiran therapy.
Further Information:
- Inclisiran: What you need to know about this cholesterol-lowering drug: https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2020/january/nhs-and-novartis-to-collaborate-to-tackle-heart-disease
- Inclisiran injection: MedlinePlus Drug Information: https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900353-9/fulltext
Disclaimer:
- I am not a medical professional and cannot provide medical advice.
- The information provided here is for educational purposes only and should not be interpreted as a substitute for professional medical consultation.